<DOC>
	<DOCNO>NCT01385748</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Clonidine Lauriad® treat chemoradiation therapy induce severe oral mucositis patient head neck cancer .</brief_summary>
	<brief_title>Efficacy Safety Study Clonidine Lauriad® Treat Oral Mucositis</brief_title>
	<detailed_description />
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Male female Aged &gt; 18 year Suffering newly diagnose squamous cell carcinoma oral cavity , oropharynx , hypopharynx larynx histologicallyconfirmed undergone resective surgery Prior neoadjuvant chemotherapy allow provide , patient experience WHO grade &gt; 2 oral mucositis neoadjuvant therapy . Patient eligible receive concurrent chemoradiation define : 1 . A continuous course conventional external beam irradiation ( IMRT eligible ) minimum cumulative radiation dose 50 Gy maximum 70 Gy , base daily dose 1.8 2.2 Gy combine platinum base chemotherapy weekly triweekly cycle . 2 . Planned radiation treatment field must include least two oral tissue site ( among right leave buccal mucosa , floor mouth , tongue , right leave soft palate ) site receive total 50 Gy maximum 70 Gy . The radiation treatment plan review designated radiation oncologist . ECOG performance status ≤2 Screening laboratory test : 1 . Haemoglobin ≥ 10g/dL 2 . Absolute neutrophil count ≥ 1500 cells/mm3 3 . Platelets ≥ 100.000/mm3 4 . Conjugated bilirubin ≤ 2 time Upper Limit Normal ( ULN ) 5 . Serum AST ALT ≤ 3 ULN 6 . Negative serum pregnancy test Women child bear potential must effective contraception method ( oral device ) Signed write informed consent Tumours lips , sinus , salivary gland Prior radiation head neck area Curative surgery less 2 week 15 week prior initiation RTCT Presence active infectious disease Presence active oral infectious disease , include oropharyngeal candidiasis and/or orofacial herpes Presence oral mucositis Known suspect chronic viral disease include HIV Systolic blood pressure &lt; 100 mmHg and/or Diastolic blood pressure &lt; 50 mmHg Recent stroke within last 6 month Bradyarrhythmia ( &lt; 60 b/min ) , include sinus node dysfunction AV nodal conduction block 2nd 3rd degree Subjects orthostatic hypotension , define decrease systolic BP and/or diastolic BP 20 mmHg patient stand Renal insufficiency ( creatinine blood level &gt; 1.5ULN ) Ongoing heavy alcohol consumption ( &gt; 100g alcohol/day ) Administration concomitant treatment likely interfere clonidine Known hypersensitivity clonidine , history allergy intolerance milk proteins component product Presence severe uncontrolled depression Pregnant breastfeed woman Inability give inform consent comply study requirement Unable unwilling comply followup visit Participation clinical trial within 30 day prior randomization entire duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>